New Research on Treatment for Ovarian Cancer: More Women Are Now Eligible to Receive a PARP Inhibitor

Updated September 5th, 2019

New Research on Treatment for Ovarian Cancer: More Women Are Now Eligible to Receive a PARP Inhibitor

New research shows that ovarian cancers without BRCA mutations—as well as cancers that haven't responded to chemotherapy in the past—may benefit from PARP inhibitors, too.

NOW
PLAYING
Nightbirde Withdraws From 'AGT' Amid Breast Cancer Battle
NOW
PLAYING
Brave Siblings, 7 and 2, Fight Back After Childhood Cancer Diagnoses
NOW
PLAYING
Buffalo Bills Coach Sean McDermott on Skin Cancer, Jim Johnson
NOW
PLAYING
Nene Leakes Husband Gregg Back Home After Colon Cancer Diagnosis
NOW
PLAYING
Beloved Atlanta News Anchor Jovita Moore Diagnosed with Glioblastoma
NOW
PLAYING
FDA: Risks to Myeloma Patients Taking Pepaxto After Deaths in Trial

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.